MD Anderson experts return to Palm Beach for educational seminar
Experts from The University of Texas MD Anderson Cancer Center return to Palm Beach Wednesday, Jan. 11 for the Making Cancer History®...
Childhood cancer leader joins MD Anderson to lead Pediatrics
Richard Gorlick, M.D., an internationally recognized expert in pediatric oncology and hematology, today joined The University of Texas...
Checkpoint inhibitors shrink tumors of metastatic bladder...
Combination immunotherapy is producing response rates ranging from 26 to 38 percent among patients with metastatic bladder cancer in...
MD Anderson named top-ranked cancer hospital in annual survey
The University of Texas MD Anderson Cancer Center again has ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best...
Saks Fifth Avenue to host event benefiting MD Anderson
The University of Texas MD Anderson Cancer Center and Saks Fifth Avenue will join forces April 27 at a cocktail and store preview...
MD Anderson experts join new Parker Institute for Cancer...
Cancer immunotherapy leaders at The University of Texas MD Anderson Cancer Center will work with experts at five other cancer centers...
MD Anderson, AbbVie connect to advance cancer immunotherapy
The immunotherapy platform at The University of Texas MD Anderson Cancer Center and the global biopharmaceutical company AbbVie will...
MD Anderson Applauds State of the Union Call to Cure Cancer
The University of Texas MD Anderson Cancer Center is grateful Vice President Joe Biden has inspired the creation of a national cancer...
Study reveals potential therapy targets for triple-negative...
In cancer, cell signaling pathways are the critical chain of events that can either quash or quicken disease progression.
A...